Login / Signup

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

S F JørgensenM E MacphersonT BjørnetrøK HolmM KummenA RashidiA E MichelsenTove LekvaB HalvorsenM TrøseidT E MollnesR K BergeA YndestadT UelandT H KarlsenP AukrustJohannes Roksund HovB Fevang
Published in: Scientific reports (2024)
Keyphrases
  • irritable bowel syndrome